20/20 BioLabs’ Multi-Cancer Early Detection Test Now Available to Evexia Diagnostics’ 40,000+ U.S. Practitioners

Evexia Diagnostics now offers 20/20 BioLabs’ OneTest™ MCED test, giving clinicians affordable, biomarker insights for ...
Seeking Alpha

20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities

Recently Nasdaq-Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific Research to Deliver Personalized Health Insights GAITHERSBURG ...

20/20 Biolabs Inc.: 20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program

Inflammatory Biomarker Tracking Predicted to Enhance Response to 3-D Bio-Printed Therapies Expands OneTest for Longevity with Chronic Kidney Disease Risk Assessment GAITHERSBURG, Md., March 24, 2026 ...
TMCnet

Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest ™ Multi-Cancer Early Detection Blood Test

State-Funded Screening Initiative Highlights Growing Public Sector Support for Innovative Cancer Detection Tools .
Yahoo Finance

20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth

Company Ready to Scale Growth through OneTest™ AI-Powered Blood Tests for Cancer and Longevity GAITHERSBURG, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX), an early market ...
Investing

20/20 BioLabs begins trading on Nasdaq under AIDX ticker

GAITHERSBURG, Md. - 20/20 BioLabs, Inc. (NASDAQ:AIDX) began trading on the Nasdaq Capital Market Thursday under the ticker symbol AIDX, marking the company’s transition to a publicly traded entity.
Finanznachrichten

20/20 Biolabs Inc.: 20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth

Company Ready to Scale Growth through OneTest AI-Powered Blood Tests for Cancer and Longevity GAITHERSBURG, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX), an early market ...
The Daily Reflector

Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ ...

State-Funded Screening Initiative Highlights Growing Public Sector Support for Innovative Cancer Detection Tools ...